The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Esomeprazole 20 mg gastro-resistant tablets



Brillpharma (Ireland) LimitedPA22749/023/001

Main Information

Trade NameEsomeprazole 20 mg gastro-resistant tablets
Active SubstancesEsomeprazole
Dosage FormGastro-resistant tablet
Licence HolderBrillpharma (Ireland) Limited
Licence NumberPA22749/023/001

Group Information

ATC CodeA02BC Proton pump inhibitors
A02BC05 esomeprazole

Status

License statusAuthorised
Licence Issued29/03/2018
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0004-003-016
Interchangeable List DocumentPDF of Interchangeable List
« Back